These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 6983601

  • 1. [Immunotherapeutic effect of orally administered BCG on experimental lung metastasis of subcutaneous fibrosarcoma in guinea pigs].
    Fujisawa S.
    Nihon Hifuka Gakkai Zasshi; 1982; 92(8):871-81. PubMed ID: 6983601
    [No Abstract] [Full Text] [Related]

  • 2. [Antitumor effect of bacterial preparations. 1. Effect of BCG on tumors of guinea pigs].
    Tokunaga T, Kataoka T.
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):214. PubMed ID: 1240246
    [No Abstract] [Full Text] [Related]

  • 3. Immunotherapeutic trials of murine and guinea-pig solid tumors by oral administration of BCG.
    Tokunaga T, Taguchi S, Chino F, Murohashi T.
    Jpn J Med Sci Biol; 1979 Feb; 32(1):1-18. PubMed ID: 470220
    [Abstract] [Full Text] [Related]

  • 4. Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy.
    Morton DL, Eilber FR, Joseph WL, Wood WC, Trahan E, Ketcham AS.
    Ann Surg; 1970 Oct; 172(4):740-9. PubMed ID: 5272336
    [No Abstract] [Full Text] [Related]

  • 5. Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.
    Simmons RL, Rios A.
    Natl Cancer Inst Monogr; 1973 Dec; 39():57-68. PubMed ID: 4595327
    [No Abstract] [Full Text] [Related]

  • 6. Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-Guérin and neuraminidase.
    Sparks FC, Breeding JH.
    Cancer Res; 1974 Dec; 34(12):3262-9. PubMed ID: 4471640
    [No Abstract] [Full Text] [Related]

  • 7. [Anti-tumor activity of BCG-CWS].
    Ogura T, Sakaya M, Naniwa M, Yamamura Y.
    Kekkaku; 1980 Oct; 55(10):470-2. PubMed ID: 7230588
    [No Abstract] [Full Text] [Related]

  • 8. Mechanism of Bacillus Calmette-Guérin-induced suppression of metastases in a poorly immunogenic fibrosarcoma.
    Liotta LA, Kleinerman J, Saidel GM.
    Cancer Res; 1976 Sep; 36(9 pt.1):3255-9. PubMed ID: 788897
    [Abstract] [Full Text] [Related]

  • 9. Successful immunotherapy with BCG as an adjunct to surgical resection for murine fibrosarcoma.
    Sonis ST, Stelos P, Wilson RE.
    Surg Forum; 1975 Sep; 26():133-5. PubMed ID: 1216088
    [No Abstract] [Full Text] [Related]

  • 10. A rapid method for the production of fibrosarcoma in rats and the effect of BCG administration.
    Nagarajan B, Sankaran S.
    Indian J Cancer; 1973 Mar; 10(1):83-4. PubMed ID: 4714069
    [No Abstract] [Full Text] [Related]

  • 11. Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.
    Yron I, Weiss DW, Robinson E, Cohen D, Adelberg MG, Mekori T, Haber M.
    Natl Cancer Inst Monogr; 1973 Dec; 39():33-55. PubMed ID: 4362523
    [No Abstract] [Full Text] [Related]

  • 12. Responses of tumors induced in inbred guinea pig strain JY=1 and strain Hartley/F to BCG.
    Kataoka T, Tokunaga T, Murohashi T.
    J Natl Cancer Inst; 1977 Mar; 58(3):803-8. PubMed ID: 320348
    [Abstract] [Full Text] [Related]

  • 13. Suppression of transplanted rat sarcomata mediated by Bacillus Calmette Guéin (BCG).
    Moore M, Lawrence N, Witherow PJ.
    Eur J Cancer (1965); 1974 Oct; 10(10):673-82. PubMed ID: 4533899
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of mice with lung metastasis from a dermally implanted fibrosarcoma: comparison of intratumoral trehalose-6,6'-dimycolate (cord factor) and surgery.
    Yarkoni E, Rapp HJ, Hunter JT.
    Eur J Cancer (1965); 1981 Mar; 17(3):291-5. PubMed ID: 7262166
    [No Abstract] [Full Text] [Related]

  • 15. Preparation of immunotherapeutic autologous tumor cell vaccines from solid tumors.
    Peters LC, Brandhorst JS, Hanna MG.
    Cancer Res; 1979 Apr; 39(4):1353-60. PubMed ID: 217533
    [No Abstract] [Full Text] [Related]

  • 16. Morphological and functional aspects of active specific immunotherapy of established pulmonary metastases in guinea pigs.
    Hanna MG, Peters LC.
    Cancer Res; 1981 Oct; 41(10):4001-9. PubMed ID: 7285011
    [No Abstract] [Full Text] [Related]

  • 17. BCG immunotherapy of rat tumors of defined immunogenicity.
    Baldwin RW, Pimm MV.
    Natl Cancer Inst Monogr; 1973 Dec; 39():11-9. PubMed ID: 4595312
    [No Abstract] [Full Text] [Related]

  • 18. Cancer research coordinating committee launches nation-wide BCG trials in treatment of lung cancer.
    Best J.
    Can Med Assoc J; 1973 Nov 03; 109(9):925 passim. PubMed ID: 4750308
    [No Abstract] [Full Text] [Related]

  • 19. Influence of preexisting tumor immunity on Bacillus Calmette-Guérin immunotherapy of guinea pigs with both regional and disseminated tumor.
    Jessup JM, Riggs CW, Hanna MG.
    Cancer Res; 1977 Aug 03; 37(8 Pt 1):2565-73. PubMed ID: 872084
    [No Abstract] [Full Text] [Related]

  • 20. Toxicity of intrapleural Bacillus Calmette-Guérin treatment in animals.
    Filardi MJ, Codish SD, Civerchia L, Howard RK, McKneally MF.
    Cancer Res; 1979 Sep 03; 39(9):3673-6. PubMed ID: 383285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.